ArticleAmerican journal of cancer research2022

Signature of the vascular tumor microenvironment as a marker of the therapeutic response to doxorubicin in a preclinical model of osteosarcoma.

Vincent Crenn et al.PubMed ↗Full text ↗

No numbers read from the abstract.